Northwestern Mutual Wealth Management
AVXL icon

Northwestern Mutual Wealth Management’s Anavex Life Sciences AVXL Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$388 Sell
150
-2,242
-94% -$6.63K ﹤0.01% 3908
2026
Q1 		$7.34K Sell
2,392
-500
-17% -$2.17K ﹤0.01% 3178
2025
Q4 		$10.3K Sell
2,892
-1,239
-30% -$7.59K ﹤0.01% 2977
2025
Q3 		$36.8K Sell
4,131
-8,916
-68% -$90.4K ﹤0.01% 2454
2025
Q2 		$120K Sell
13,047
-1,824
-12% -$15.6K ﹤0.01% 1938
2025
Q1 		$128K Sell
14,871
-12,698
-46% -$120K ﹤0.01% 1840
2024
Q4 		$296K Buy
+27,569
New +$212K ﹤0.01% 1501
2023
Q4 		– Sell
-1,335
Closed -$8.74K – 3479
2023
Q3 		$8.74K Buy
+1,335
New +$10.6K ﹤0.01% 2584

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northwestern Mutual Wealth Management's AVXL Position: Q2 2026 in Review

Northwestern Mutual Wealth Management reduced its Anavex Life Sciences (AVXL) stake by 94% in Q2 2026, selling an estimated $6.63K and leaving 150 shares worth $388. The position accounts for ﹤0.01% of the portfolio, ranked #3908.

Northwestern Mutual Wealth Management first reported a position in AVXL in Q3 2023 and has held it in 8 quarters since. The position peaked at $296K in Q4 2024. 180 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Northwestern Mutual Wealth Management held 150 shares of Anavex Life Sciences worth $388 as of Q2 2026.
  • Northwestern Mutual Wealth Management sold 2,242 Anavex Life Sciences shares in Q2 2026, an estimated $6.63K.
  • Anavex Life Sciences made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3908 holding.
  • Northwestern Mutual Wealth Management first reported a position in Anavex Life Sciences in Q3 2023 and has held it in 8 quarters since.
  • Northwestern Mutual Wealth Management's Anavex Life Sciences position peaked at $296K in Q4 2024.
  • 180 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.